Hummingbird gets green light for Covid-19 antibody clinical trial study

📆 10/28/2020 12:55 PM
📰 BusinessTimes

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 51%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

BIOTECH startup Hummingbird Biosciences has received approval from Singapore's Health Sciences Authority (HSA) for a clinical trial to study its experimental antibody therapy against SARS-CoV-2, the virus that causes Covid-19. Read more at The Business Times.

BIOTECH startup Hummingbird Biosciences has received approval from Singapore's Health Sciences Authority for a clinical trial to study its experimental antibody therapy against SARS-CoV-2, the virus that causes Covid-19.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Law Law Latest News, Law Law Headlines